Flotek Industries (FTK) Q2 2024 earnings summary

Executive summary

• Achieved $46.2M in Q2 2024 revenue, up 14% sequentially, with strong growth in chemistry and data analytics segments, despite a 9% year-over-year decline due to lower related party activity.

• Net income reached $2.0M in Q2 2024, reversing a net loss of $21K in Q2 2023; adjusted EBITDA improved to $4.4M from negative $2.0M year-over-year, marking the fourth consecutive quarter of net income and seventh of adjusted EBITDA improvement.

• External chemistry sales rose 40% sequentially, with Permian Basin revenues up 186% sequentially and 68% year-over-year; data analytics segment revenue increased 22% sequentially.

• EPA approval of the JP3 Analyzer system opens a $220M annual addressable market for flare emission monitoring, with over 50 flare site orders received, all on a subscription basis.

• All operational achievements were accomplished with zero recordable and lost time incidents.

Financial highlights

• Q2 2024 total revenue was $46.2M, up 14% sequentially but down 9% year-over-year, driven by external chemistry sales and Contract Shortfall Fees.

• Gross profit increased to $9.2M, a 136% year-over-year rise; gross profit margin reached 20% (adjusted: 23%), up from 8% (adjusted: 10%) a year ago.

• Adjusted EBITDA for Q2 2024 was $4.4M, up from negative $2.0M in Q2 2023; trailing twelve-month adjusted EBITDA reached $15.8M.

• SG&A expenses declined to $6.3M from $8.4M year-over-year, mainly due to lower professional fees.

• Net income per diluted share was $0.06 in Q2 2024, compared to a loss of $0.11 per share in Q2 2023.

Outlook and guidance

• Raised full-year 2024 adjusted EBITDA guidance to $14M–$18M, a 23% increase at the midpoint, with the midpoint representing over 900% improvement from 2023.

• 2024 adjusted gross profit margin expected between 18% and 22%, up from 15% in 2023.

• Management expects EPA approval of JP3 analyzer to drive revenue growth in late 2024 and into 2025, with flare monitoring orders expected to accelerate.

• Expects industry activity to rebound in 2025 and accelerate in 2026 as E&P consolidation completes.

• The company does not expect to meet minimum purchase requirements under the ProFrac Agreement for 2024, resulting in recognition of $17.1M in Contract Shortfall Fees, to be collected in Q1 2025.